Hijacking the hedgehog pathway in cancer therapy

Anti-Cancer Agents in Medicinal Chemistry

Volumn 16, Issue 3, 2016, Pages 309-317

  Laukkanen, Mikko O ^a   Castellone, Maria Domenica ^b  

^a IRCCS SDN   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cancer; Hedgehog pathway; Target therapy

Indexed keywords

ARSENIC TRIOXIDE; AZACITIDINE; BEVACIZUMAB; BMS 833923; BORTEZOMIB; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPAMINE; CYTARABINE; DASATINIB; DEXAMETHASONE; ETOPOSIDE; FLUOROURACIL; FOLINATE CALCIUM; GAMMA SECRETASE; GEFITINIB; GEMCITABINE; GLASDEGIB; GOSERELIN; LENALIDOMIDE; LEUPRORELIN; OXALIPLATIN; SONIC HEDGEHOG PROTEIN; SONIDEGIB; TALADEGIB; TEMOZOLOMIDE; TRANSCRIPTION FACTOR; UNINDEXED DRUG; VISMODEGIB; G PROTEIN COUPLED RECEPTOR; ONCOPROTEIN; SMO PROTEIN, HUMAN; SMOOTHENED PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR GLI1;

ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CANCER THERAPY; CELL PROLIFERATION; DOWN REGULATION; DRUG APPROVAL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; MEDULLOBLASTOMA; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROSTATE TUMOR; SIGNAL TRANSDUCTION; SMALL CELL LUNG CANCER; SOLID TUMOR; ANTAGONISTS AND INHIBITORS; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS;

CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; HEDGEHOG PROTEINS; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SMOOTHENED RECEPTOR; TRANS-ACTIVATORS; ZINC FINGER PROTEIN GLI1;

EID: 84958969576     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/1871520615666151007160439     Document Type: Article

References (60)

1. Howlader, N.; Noone, A. M.; Krapcho, M.; Garshell, J.; Neyman, N.; Altekruse, S. F.; Kosary, C. L.; Yu, M.; Ruhl, J.; Tatalovich, Z.; Cho, H.; Mariotto, A.; Lewis, D. R.; Chen, H. S.; Feuer, E. J.; Cronin, K. A. SEER Cancer Statistics Review, 1975-2010 (National Cancer Institute, Bethesda, MD).
2. Nusslein-Volhard, C.; Wieschaus, E. Mutations affecting segment number and polarity in drosophila. Nature, 1980, 287, 795-801.
3. Ingham, P. W.; McMahon, A. P. Hedgehog signaling in animal development: Paradigms and principles. Gen. Dev., 2001, 15, 3059-3087.
4. Van den Brink, G. R. Hedgehog signaling in development and homeostasis of the gastrointestinal tract. Physiol. Rev., 2007, 87, 1343-1375.
5. Varjosalo, M; Taipale, J. Hedgehog: Functions and mechanisms. Gen. Dev., 2008, 22, 2454-2472.
6. Eggenschwiler, J. T.; Anderson, K. V. Cilia and developmental signaling. Annu. Rev. Cell. Dev. Biol., 2007, 23, 345-373.
7. Wong, S. Y.; Reiter, J. F. The primary cilium at the crossroads of mammalian hedgehog signaling. Curr. Top. Dev. Biol., 2008, 85, 225-260.
8. Thayer, S. P.; Di Magliano, M. P.; Heiser, P. W.; Nielsen, C. M.; Roberts, D. J.; Lauwers, G. Y.; Qi, Y. P.; Gysin, S.; Fernandez-del Castillo, C.; Yajnik, V.; Antoniu, B.; McMahon, M.; Warshaw, A. L.; Hebrok, M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature, 2003, 425, 851-856.
9. Tian, H.; Callahan, C. A.; DuPree, K. J.; Darbonne, W. C.; Ahn, C. P.; Scales, S. J.; De Sauvage, F. J. Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc. Natl. Acad. Sci. USA, 2009, 106, 4254-4259.
10. Bailey, J. M.; Swanson, B. J.; Hamada, T.; Eggers, J. P.; Singh, P. K.; Caffery, T.; Ouellette, M. M.; Hollingsworth, M. A. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin. Cancer Res., 2008, 14, 5995-6004.
11. Park, K. S.; Martelotto, L. G.; Peifer, M.; Sos, M. L.; Karnezis, A. N.; Mahjoub, M. R.; Bernard, K.; Conklin, J. F.; Szczepny, A.; Yuan, J.; Guo, R.; Ospina, B.; Falzon, J.; Bennett, S.; Brown, T. J.; Markovic, A.; Devereux, W. L.; Ocasio, C. A.; Chen, J. K.; Stearns, T.; Thomas, R. K.; Dorsch, M.; Buonamici, S.; Watkins, D. N.; Peacock, C. D.; Sage, J. A crucial requirement for Hedgehog signaling in small cell lung cancer. Nat. Med., 2011, 17, 1504-1508.
12. Hahn, H.; Christiansen, J.; Wicking, C.; Zaphiropoulos, P. G.; Chidambaram, A.; Gerrard, B.; Vorechovsky, I.; Bale, A. E.; Toftgard, R.; Dean, M.; Wainwright, B. A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities. J. Biol. Chem., 1996, 271, 12125-1218.
13. Kool, M.; Jones, D. T.; Jager, N.; Northcott, P. A.; Pugh, T. J.; Hovestadt, V.; Piro, R. M.; Esparza, L. A.; Markant, S. L.; Remke, M.; Milde, T.; Bourdeaut, F.; Ryzhova, M.; Sturm, D.; Pfaff, E.; Stark, S.; Hutter, S.; Seker-Cin, H.; Johann, P.; Bender, S.; Schmidt, C.; Rausch, T.; Shih, D.; Reimand, J.; Sieber, L.; Wittmann, A.; Linke, L.; Witt, H.; Weber, U. D.; Zapatka, M.; Konig, R.; Beroukhim, R.; Bergthold, G.; van Sluis, P.; Volckmann, R.; Koster, J.; Versteeg, R.; Schmidt, S.; Wolf, S.; Lawerenz, C.; Bartholomae, C. C.; von Kalle, C.; Unterberg, A.; Herold-Mende, C, Hofer, S.; Kulozik, A. E.; Von Deimling, A.; Scheurlen, W.; Felsberg, J.; Reifenberger, G.; Hasselblatt, M.; Crawford, J. R.; Grant, G. A.; Jabado, N.; Perry, A.; Cowdrey, C.; Croul, S.; Zadeh, G.; Korbel, J. O.; Doz, F.; Delattre, O.; Bader, G. D.; McCabe, M. G.; Collins, V. P.; Kieran, M. W.; Cho, Y. J.; Pomeroy, S. L.; Witt, O.; Brors, B.; Taylor, M. D.; Schuller, U.; Korshunov, A.; Eils, R.; Wechsler-Reya, R. J.; Lichter, P.; Pfister S. M. ICGC PedBrain tumor project. genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell, 2014, 25, 393-405.
14. Northcott, P. A.; Jones, D. T.; Kool, M.; Robinson, G. W.; Gilbertson, R. J.; Cho, Y. J.; Pomeroy, S. L.; Korshunov, A.; Lichter, P.; Taylor, M. D.; Pfister, S. M. Medulloblastomics: The end of the beginning. Nat. Rev. Cancer, 2012, 12, 818-834.
15. Yang, Z. J.; Ellis, T.; Markant, S. L.; Read, T. A.; Kessler, J. D.; Bourboulas, M.; Schuller, U.; Machold, R.; Fishell, G.; Rowitch, D. H.; Wainwright, B. J.; Wechsler-Reya, R. J. Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells. Cancer Cell, 2008, 14, 135-145.
16. Scales, S. J.; De Sauvage, F. J. Mechanisms of hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol. Sci., 2009, 30, 303-312.
17. Rubin, L. L.; De Sauvage, F. J. Targeting the hedgehog pathway in cancer. Nat. Rev. Drug. Discov., 2006, 5, 1026-1033.
18. Gialmanidis, I. P.; Bravou, V.; Amanetopoulou, S. G.; Varakis, J.; Kourea, H.; Papadaki, H. Overexpression of hedgehog pathway molecules and FOXM1 in non-small cell lung carcinomas. Lung Cancer, 2009, 66, 64-74.
19. Bailey, J. M.; Mohr, A. M.; Hollingsworth, M. A. Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene, 2009, 28, 3513-3525.
20. Yauch, R. L.; Gould, S. E.; Scales, S. J.; Tang, T.; Tian, H.; Ahn, C. P.; Marshall, D.; Fu, L.; Januario, T.; Kallop, D.; Nannini-Pepe, M.; Kotkow, K.; Marsters, J. C.; Rubin, L. L.; De Sauvage, F. J. A paracrine requirement for hedgehog signalling in cancer. Nature, 2008, 455, 406-410.
21. Mills, L. D.; Zhang, Y.; Marler, R. J.; Herreros-Villanueva, M.; Zhang, L.; Almada, L. L.; Couch, F.; Wetmore, C.; Pasca di Magliano, M.; Fernandez-Zapico, M. E. Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation. J. Biol. Chem., 2013, 288, 11786-11794.
22. Olive, K. P.; Jacobetz, M. A.; Davidson, C. J.; Gopinathan, A.; McIntyre, D.; Honess, D.; Madhu, B.; Goldgraben, M. A.; Caldwell, M. E.; Allard, D.; Frese, K. K.; Denicola, G.; Feig, C.; Combs, C.; Winter, S. P.; Ireland-Zecchini, H.; Reichelt, S.; Howat, W. J.; Chang, A.; Dhara, M.; Wang, L.; Ruckert, F.; Grutzmann, R.; Pilarsky, C.; Izeradjene, K.; Hingorani, S. R.; Huang, P.; Davies, S. E.; Plunkett, W.; Egorin, M.; Hruban, R. H.; Whitebread, N.; McGovern, K.; Adams, J.; Iacobuzio-Donahue, C.; Griffiths, J.; Tuveson, D. A. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science, 2009, 324, 1457-1461.
23. Chang, Q.; Foltz, W. D.; Chaudary, N.; Hill, R. P.; Hedley, D. W. Tumor-stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition. Int. J. Cancer, 2013, 133, 225-234.
24. Dierks, C.; Grbic, J.; Zirlik, K.; Beigi, R.; Englund, N. P.; Guo, G. R.; Veelken, H.; Engelhardt, M.; Mertelsmann, R.; Kelleher, J. F.; Schultz, P.; Warmuth, M. Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat. Med., 2007, 13, 944-951.
25. Ok, C. Y.; Singh, R. R.; Vega, F. Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms. Am. J. Pathol., 2012, 180, 2-11.
26. Rhim, A. D.; Oberstein, P. E.; Thomas, D. H.; Mirek, E. T.; Palermo, C. F.; Sastra, S. A.; Dekleva, E. N.; Saunders, T.; Becerra, C. P.; Tattersall, I. W.; Westphalen, C. B.; Kitajewski, J.; Fernandez-Barrena, M. G.; Fernandez-Zapico, M. E.; Iacobuzio-Donahue, C.; Olive, K. P.; Stanger, B. Z. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell, 2014, 25, 735-747.
27. Ozdemir, B. C.; Pentcheva-Hoang, T.; Carstens, J. L.; Zheng, X.; Wu, C. C.; Simpson, T. R.; Laklai, H.; Sugimoto, H.; Kahlert, C.; Novitskiy, S. V.; De Jesus-Acosta, A.; Sharma, P.; Heidari, P.; Mahmood, U.; Chin, L.; Moses, H. L.; Weaver, V. M.; Maitra, A.; Allison, J. P.; LeBleu, V. S.; Kalluri, R. Depletion of carcinomaassociated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell, 2014, 25, 719-734.
28. Lee, J. J.; Perera, R. M.; Wang, H.; Wu, D. C.; Liu, X. S.; Han, S.; Fitamant, J.; Jones, P. D.; Ghanta, K. S.; Kawano, S.; Nagle, J. M.; Deshpande, V.; Boucher, Y.; Kato, T.; Chen, J. K.; Willmann, J. K.; Bardeesy, N.; Beachy, P. A. Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proc. Natl. Acad. Sci. USA, 2014, 111, E3091-100.
29. Stecca, B.; Ruiz i Altaba, A. A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J., 2009, 28, 663-676.
30. Riobo, N. A.; Lu, K.; Ai, X.; Haines, G. M.; Emerson, C. P. Jr. Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. Proc. Natl. Acad. Sci. USA, 2006, 103, 4505-4510.
31. Jagani, Z.; Mora-Blanco, E. L.; Sansam, C. G.; McKenna, E. S.; Wilson, B.; Chen, D.; Klekota, J.; Tamayo, P.; Nguyen, P. T.; Tolstorukov, M.; Park, P. J.; Cho, Y. J.; Hsiao, K.; Buonamici, S.; Pomeroy, S. L.; Mesirov, J. P.; Ruffner, H.; Bouwmeester, T.; Luchansky, S. J.; Murtie, J.; Kelleher, J. F.; Warmuth, M.; Sellers, W. R.; Roberts, C. W.; Dorsch, M. Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway. Nat. Med., 2010, 16, 1429-1433.
32. Gurung, B.; Feng, Z.; Iwamoto, D. V.; Thiel, A.; Jin, G.; Fan, C. M.; Ng, J. M.; Curran, T.; Hua, X. Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome. Cancer Res., 2013, 73, 2650-2658.
33. Ji, Z.; Mei, F. C.; Xie, J.; Cheng, X. Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells. J. Biol. Chem., 2007, 282, 14048-14055.
34. Aberger, F.; Ruiz I Altaba, A. Context-dependent signal integration by the GLI code: The oncogenic load, pathways, modifiers and implications for cancer therapy. Semin. Cell. Dev. Biol., 2014, 33, 93-104.
35. Wang, Y.; Ding, Q.; Yen, C. J.; Xia, W.; Izzo, J. G.; Lang, J. Y.; Li, C. W.; Hsu, J. L.; Miller, S. A.; Wang, X.; Lee, D. F.; Hsu, J. M.; Huo, L.; Labaff, A. M.; Liu, D.; Huang, T. H.; Lai, C. C.; Tsai, F. J.; Chang, W. C.; Chen, C. H.; Wu, T. T.; Buttar, N. S.; Wang, K. K.; Wu, Y.; Wang, H.; Ajani, J.; Hung, M. C. The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell, 2012, 21, 374-387.
36. Chuang, P. T.; McMahon, A. P. Vertebrate hedgehog signalling modulated by induction of a hedgehog-binding protein. Nature, 1999, 397, 617-621.
37. Weaver, M.; Batts, L.; Hogan, B. L. Tissue interactions pattern the mesenchyme of the embryonic mouse lung. Dev. Biol., 2003, 258, 169-184.
38. Polizio, A. H.; Chinchilla, P.; Chen, X.; Kim, S.; Manning, D. R.; Riobo, N. A. Heterotrimeric Gi proteins link Hedgehog signaling to activation of Rho small GTPases to promote fibroblast migration. J. Biol. Chem., 2011, 286, 19589-19596.
39. Yang, L.; Xie, G.; Fan, Q.; Xie, J. Activation of the hedgehogsignaling pathway in human cancer and the clinical implications. Oncogene, 2010, 29, 469-481.
40. Gould, S. E.; Low, J. A.; Marsters, J. C. Jr.; Robarge, K.; Rubin, L. L.; De Sauvage, F. J.; Sutherlin, D. P.; Wong, H.; Yauch, R. L. Discovery and preclinical development of vismodegib. Exp. Opin. Drug. Discov., 2014, 9, 969-984.
41. Amakye, D.; Jagani, Z.; Dorsch, M. Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nat. Med., 2013, 19, 1410-422.
42. Dijkgraaf, G. J.; Alicke, B.; Weinmann, L.; Januario, T.; West, K.; Modrusan, Z.; Burdick, D.; Goldsmith, R.; Robarge, K.; Sutherlin, D.; Scales, S. J.; Gould, S. E.; Yauch, R. L.; De Sauvage, F. J. Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance. Cancer Res., 2011, 71, 435-444.
43. Tao, H.; Jin, Q.; Koo, D. I.; Liao, X.; Englund, N. P.; Wang, Y.; Ramamurthy, A.; Schultz, P. G.; Dorsch, M.; Kelleher, J.; Wu, X. Small molecule antagonists in distinct binding modes inhibit drugresistant mutant of smoothened. Chem. Biol., 2011, 18, 432-437.
44. Maun, H. R.; Wen, X.; Lingel, A.; de Sauvage, F. J.; Lazarus, R. A.; Scales, S. J.; Hymowitz, S. G. Hedgehog pathway antagonist 5E1 binds hedgehog at the pseudo-active site. J. Biol. Chem., 2010, 285, 26570-26580.
45. Stanton, B. Z.; Peng, L. F.; Maloof, N.; Nakai, K.; Wang, X.; Duffner, J. L.; Taveras, K. M.; Hyman, J. M.; Lee, S. W.; Koehler, A. N.; Chen, J. K.; Fox, J. L.; Mandinova, A.; Schreiber, S. L. A small molecule that binds Hedgehog and blocks its signaling in human cells. Nat. Chem. Biol., 2009, 5, 154-156.
46. Hyman, J. M.; Firestone, A. J.; Heine, V. M.; Zhao, Y.; Ocasio, C. A.; Han, K.; Sun, M.; Rack, P. G.; Sinha, S.; Wu, J. J.; Solow-Cordero, D. E.; Jiang, J.; Rowitch, D. H.; Chen, J. K. Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade. Proc. Natl. Acad. Sci. U SA, 2009, 106, 14132-14137.
47. Lauth, M.; Bergstrom, A.; Shimokawa, T.; Toftgard, R. Inhibition of GLI-mediated transcription and tumor cell growth by smallmolecule antagonists. Proc. Natl. Acad. Sci. USA, 2007, 104, 8455-8460.
48. Beauchamp, E. M.; Ringer, L.; Bulut, G.; Sajwan, K. P.; Hall, M. D.; Lee, Y. C.; Peaceman, D.; Ozdemirli, M.; Rodriguez, O.; Macdonald, T. J.; Albanese, C.; Toretsky, J. A.; Uren, A. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. J. Clin. Invest., 2011, 121, 148-160.
49. Kim, J.; Lee, J. J.; Kim, J.; Gardner, D.; Beachy, P. A. Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector. Proc. Natl. Acad. Sci. USA, 2010, 107, 13432-13437.
50. Mimeault, M.; Batra, S. K. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies. Pharmacol. Rev., 2010, 62, 497-524.
51. Stecca, B.; Ruiz I Altaba, A. Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. J. Mol. Cell. Biol., 2010, 2, 84-95.
52. Mangelberger, D.; Kern, D.; Loipetzberger, A.; Eberl, M.; Aberger, F. Cooperative Hedgehog-EGFR signaling. Front. Biosci., 2012, 17, 90-99.
53. Gotschel, F.; Berg, D.; Gruber, W.; Bender, C.; Eberl, M.; Friedel, M.; Sonntag, J.; Rungeler, E.; Hache, H.; Wierling, C.; Nietfeld, W.; Lehrach, H.; Frischauf, A.; Schwartz-Albiez, R.; Aberger, F.; Korf, U. Synergism between Hedgehog-GLI and EGFR signaling in Hedgehog-responsive human medulloblastoma cells induces downregulation of canonical Hedgehog-target genes and stabilized expression of GLI1. PLoSOne, 2013, 8, 65403.
54. Brechbiel, J.; Miller-Moslin, K.; Adjei, A. A. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer. Cancer Treat. Rev., 2014, 40, 750-759.
55. Ahmad, A.; Maitah, M. Y.; Ginnebaugh, K. R.; Li, Y.; Bao, B.; Gadgeel, S. M.; Sarkar, F. H. Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs. J. Hematol. Oncol., 2013, 6, 77.
56. Gruber Filbin, M.; Dabral, S. K.; Pazyra-Murphy, M. F.; Ramkissoon, S.; Kung, A. L.; Pak, E.; Chung, J.; Theisen, M. A.; Sun, Y.; Franchetti, Y.; Sun, Y.; Shulman, D. S.; Redjal, N.; Tabak, B.; Beroukhim, R.; Wang, Q.; Zhao, J.; Dorsch, M.; Buonamici, S.; Ligon, K. L.; Kelleher, J. F.; Segal, R. A. Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: New therapeutic opportunities. Nat. Med., 2013, 19, 1518-1523.
57. Wang, S.; Lee, Y.; Kim, J.; Hyun, J.; Lee, K.; Kim, Y.; Jung, Y. Potential role of Hedgehog pathway in liver response to radiation. PLoSOne, 2013, 8, 74141.
58. Ma, J.; Tian, L.; Cheng, J.; Chen, Z.; Xu, B.; Wang, L.; Li, C.; Huang, Q. Sonic hedgehog signaling pathway supports cancer cell growth during cancer radiotherapy. PloS One, 2013, 8, 65032.
59. Chai, F.; Zhou, J.; Chen, C.; Xie, S.; Chen, X.; Su, P.; Shi, J. The Hedgehog inhibitor cyclopamine antagonizes chemoresistance of breast cancer cells. Onco. Targets Ther., 2013, 6, 1643-1647.
60. Castellone, M. D.; Laukkanen, M. O.; Teramoto, H.; Bellelli, R.; Alì, G.; Fontanini, G.; Santoro, M.; Gutkind JS. Cross talk between the bombesin neuropeptide receptor and Sonic hedgehog pathways in small cell lung carcinoma. Oncogene, 2015, 34, 1679-1687.